XML 20 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated condensed statements of cash flows - USD ($)
$ in Thousands
 3 Months Ended
Apr. 01, 2023
Apr. 02, 2022
Operating activities:    
Net loss $ (174,447) $ (14,806)
Less: Loss from discontinued operations, net of tax (74,429) (401)
Loss from continuing operations (100,018) (14,405)
Adjustments to reconcile net loss to net cash from operating activities:    
Depreciation and amortization 16,473 12,479
Provision for expected credit losses 1,079 1,152
Equity based compensation 1,846 4,889
Change in fair value of contingent consideration 287 269
Change in fair value of interest rate swap 0 (3,924)
Deferred income taxes (2,664) (17,018)
Impairment of assets 78,615 0
Foreign currency fluctuations 747 44
Other, net 224 203
Changes in operating assets and liabilities:    
Accounts receivable 13,162 4,416
Inventories (5,294) 326
Accounts payable and accrued expenses 2,331 (7,915)
Other current and noncurrent assets and liabilities (2,129) (1,535)
Net cash from operating activities - continuing operations 4,659 (21,019)
Net cash from operating activities - discontinued operations (2,169) 0
Net cash from operating activities 2,490 (21,019)
Investing activities:    
Acquisitions, net of cash acquired 0 (236)
Purchase of property and equipment (3,560) (2,960)
Investments and acquisition of distribution rights 0 (1,478)
Net cash from investing activities - continuing operations (3,560) (4,674)
Net cash from investing activities - discontinued operations (11,506) 0
Net cash from investing activities (15,066) (4,674)
Financing activities:    
Proceeds from issuance of Class A and B common stock 84 2,080
Tax withholdings on equity-based compensation 0 (3,352)
Borrowing on revolver 49,000 15,000
Payment on revolver (20,000) 0
Debt refinancing costs (1,668) 0
Payments on long-term debt 0 (4,509)
Other, net (36) (14)
Net cash from financing activities 27,380 9,205
Effect of exchange rate changes on cash 461 (71)
Net change in cash, cash equivalents and restricted cash 15,265 (16,559)
Cash, cash equivalents and restricted cash at the beginning of the period 31,837 99,213
Cash, cash equivalents and restricted cash at the end of the period 47,102 82,654
Supplemental disclosure of noncash investing and financing activities    
Accounts payable for purchase of property, plant and equipment $ 0 $ 76